Kamada clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"NCT04204252Alpha 1-AntitrypsinTerminated2026-02-19Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 220 participants (planned). After: 98 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2028. After: 19 Feb 2026.

Recruitment status changed

Before: Recruiting. After: Terminated.

Check registry source